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Abstract
Background: Pain is an enormous problem globally. Estimates suggest that 20% of adults suffer from pain globally
and 10% are newly diagnosed with chronic pain each year. Nevertheless, the problem of pain has primarily been
regarded as a medical problem, and has been little addressed by the field of public health.
Discussion: Despite the ubiquity of pain, whether acute, chronic or intermittent, public health scholars and
practitioners have not addressed this issue as a public health problem. The importance of viewing pain through a
public health lens allows one to understand pain as a multifaceted, interdisciplinary problem for which many of
the causes are the social determinants of health. Addressing pain as a global public health issue will also aid in
priority setting and formulating public health policy to address this problem, which, like most other chronic non-
communicable diseases, is growing both in absolute numbers and in its inequitable distribution across the globe.
Summary: The prevalence, incidence, and vast social and health consequences of global pain requires that the
public health community give due attention to this issue. Doing so will mean that health care providers and public
health professionals will have a more comprehensive understanding of pain and the appropriate public health and
social policy responses to this problem.
Background
By any measure, pain is an enormous global health pro-
blem. Globally, it has been estimated that 1 in 5 adults
suffer from pain and that another 1 in 10 adults are diag-
nosed with chronic pain each year [1]. While pain affects
all populations, regardless of age, sex, income, race/ethni-
city, or geography, it is not distributed equally across the
globe. Those who experience pain can experience acute,
chronic, or intermittent pain, or a combination of the
three. The four largest causes of pain are cancer, osteo-
and rheumatoid arthritis, operations and injuries, and
spinal problems, making the etiology of pain a complex,
transdisciplinary affair. Pain has multiple, serious seque-
lae including but not limited to depression, inability to
work, disrupted social relationships and suicidal
thoughts. Of those living with chronic pain, the median
time of exposure is 7 years [1].
In this article, we argue that the paradigmatic view of
pain as a symptom of disease, rather than as a disease
state itself,[2] has contributed to the neglect of this
condition in the world of public health. Raising awareness
about pain for the public health community requires
clearly defining pain as a disease state and demonstrating
why it must be a public health priority. The undertreat-
ment of pain, a persistent problem for those who experi-
ence it, only can be reduced with better diagnosis and
treatement applied from a public health framework.
Understanding pain as a disease may reduce the global
burden of this health problem and its co-morbid condi-
tions as well as potentially decrease the undertreatment
and misdiagnosis of pain. These issues ought to be among
the major priorities for public health in the next century.
Public health officials must gain a better understanding of
the magnitude and characteristics of the problem,
contribute to the development and evaluation of pain
management programs, and develop the best possible
interventions to diagnose and treat chronic pain.
Discussion
Priority Setting for Pain and Public Health
The setting of public health priorities is a complex, con-
troversial and political process. These priorities are deter-
mined, it has been argued, by those who have wealth,
political power or both [3]. In the United States, for
example, public health priorities are often set by scientific
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advisory boards such as the Institute of Medicine com-
mittee which produced in July 2011 the report Relieving
Pain in America[4]. What we see in this landmark report
is a reframing of the agenda for pain including a social
transformation of pain diagnosis, treatment, and care.
Yet even though this report argues that pain ought to be
framed as a public health issue, it fails to articulate what
ought to be as understood as most important about pain
from the perspectives of social justice, health inequities,
or even the global burdens and causes of disease.
There are multiple reasons for regarding pain as a public
health priority. The first and foremost is the staggering
prevalence of pain. Because pain is a multivalent, dynamic,
and ambiguous phenomenon, it is notoriously difficult to
quantify, and therefore caution is warranted in issuing
broad assessments regarding the epidemiology of chronic
pain across the globe. Yet, even with such limitations,
there is little question regarding its high prevalence and
incidence. 10% of the world’s population - approximately
60 million people - endure chronic pain,[1] and fairly reli-
able estimates in individual countries and regions indicate
chronic pain prevalence closer to 20-25%[5-7]. Primary
care settings in Asia, Africa, Europe, and in the Americas
had patients reporting persistent pain prevalence of 10 to
25%. Consistent estimates of chronic pain prevalence in
the U.S. range from 12 to 25%, and prevalence of 20% has
been noted in Europe [7-9]. Although there are few esti-
mates of the incidence of global chronic pain, WHO has
estimated that as many as 1 in 10 adult individuals are
newly diagnosed with chronic pain each year [1].
Moreover, aside from the prevalence and incidence of
chronic pain, both the severity of such pain and the
extent of any accompanying disability are also key factors
in assessing its burden. The evidence suggests that mod-
erate-to-severe pain is prevalent even in resource-rich
settings,[10,11] and that the combination of persistent
pain and comorbid psychological disorders produce sig-
nificant disability across the globe (as measured by
impairment of daily activities) [12].
Ultimately, as one commentator recently concluded, the
evidence is strong that “for millions of people across the
globe, excruciating pain is an inescapable reality of
life.”[13] This is true for both the developed and the devel-
oping world. Pain is therefore a global health problem, one
that significantly affects both the global North and the glo-
bal South. However, akin to the general global burden of
disease, pain and its treatment are distributed highly
unequally in both the global North and the global South,
with those most disadvantaged bearing higher burdens of
persistent pain and lesser likelihood of effective treatment.
Such inequities render the equitable treatment of pain an
ethical imperative consistent with mandates of social
justice. While the ethical implications of the inequitable
distribution of global chronic pain is properly regarded as
a top priority in global health ethics, a full explication is
beyond the scope of the current project. Here, we argue
simply that pain ought to be regarded as a global public
health priority, a point which establishes a baseline for
future ethical analyses.
Second, akin to many other chronic non-communic-
able diseases (NCDs) across the globe, chronic pain is
typically accompanied by substantial comorbidities. The
roster of chronic NCDs that are positively correlated
with chronic pain are myriad,[14] including but not lim-
ited to diabetes,[15,16] arthritis,[17] depression,[18,19]
and asthma,[20] among others. Chronic NCDs account
for over 60 percent of the global burden of mortality,[21]
with generally increasing epidemiologic trajectories
across the globe [22,23]. Because these NCDs can be
expected to increase the incidence and ultimately the
prevalence of global chronic pain, the matter of incidence
and the larger context regarding comorbid (chronic)
NCDs also justifies the treatment of chronic pain as a
global public health priority.
A Public Health Approach to Pain
Understanding pain as a public health priority helps to
explain its tight linkage with social and economic determi-
nants of health. The social epidemiologic evidence sug-
gests strongly that patterns of NCDs from the hyperlocal
to the global level are powerfully determined by the condi-
tions in which people and communities live, work, and
play [23]. Given the aforementioned comorbid relationship
between a variety of NCDs and chronic pain, one would
predict that chronic pain should correlate with some of
these social determinants of health. This prediction is
borne out in research that links with chronic pain a num-
ber of such determinants, including mental and physical
stress at work,[24,25] socioeconomic status,[26] rurality,
[27] occupational status,[28] neighborhood,[29] race,
[29,30] and education [31].
One of the most promising theories regarding the cau-
sal pathways between such social factors and poor NCD
and all-cause health outcomes is the allostatic load
hypothesis [32,33]. This theory posits that persistent
exposure to deleterious social and economic conditions
activates the human body’s fight-or-flight response to a
state of perpetuity. In turn, the persistent accumulation
of stress hormones such as cortisol has been robustly
correlated with a number of diseases and negative health
outcomes [33]. Under this theoretical framework, one
would predict a direct relationship between increased
social disadvantage and either or both the frequency
and the severity of chronic pain. Several recent analyses
bear this prediction out [34-36]. Dorner et al. found that
even at the same intensity of pain, those lowest on the
social gradient reported feeling two to three times as
disabled as compared to the highest group [34].
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Similarly, Rios and Zautra documented a significant cor-
relation between the severity of daily pain and levels of
daily financial worry [35]. Moreover, the fact that social
disadvantages tend to cluster implies that communities
suffering from any one such disadvantage are more
likely to experience others [37,38]. This clustering
results in compound effects of deleterious social and
economic conditions on health, which, given the stress-
health connection, supports a belief in the pathways
between such conditions and pain across the globe.
An enormous body of literature demonstrates quite
strongly that policy action on these social determinants
of health cannot be left to the health care sector itself
[23,39,40]. As important as medical services are to ameli-
orating disease and human suffering, medical care is
neither intended to nor generally equipped to address the
macrosocial factors that determine patterns of pain and
its distribution in populations. Understanding the power-
ful connections between deleterious social and economic
conditions and global chronic pain therefore provides
additional reason for regarding pain as a public health
priority rather than simply a medical priority.
Moreover, the primary response to the undertreatment
of pain both in the developed world and beyond has clo-
sely tracked a medical model, one which analyzes the
problem almost exclusively in context of the availability
and distribution of opioid analgesics [9,41-43]. Yet as
Ichiro Kawachi observed in the award-winning docu-
mentary Unnatural Causes, however useful aspirin may
be in the treatment of fever, the cause of fever is not
lack of aspirin [44]. Moreover, while there is no ques-
tion that access to essential medicines is a global health
priority, the Final Report of the WHO’s Commission on
the Social Determinants of Health makes plain the
abundant evidence that remedies for the most pressing
and inequitable global health problems are typically to
be found outside the provision of health care services
[23]. Thus, this essay strikes outside the confines of the
medical model, and argues that global chronic pain
ought to be perceived as a public health priority.
Finally, regarding chronic pain as a global public health
priority could have a salutary effect on chronic pain
research. Where the medical model dominates research
and funding on pain, research allocation is similarly
skewed towards basic science (pain at the molecular level)
and to clinical medicine, the latter consisting largely of a
focus on medical treatments and health care services.
Given the likelihood that many of the key determinants of
pain across the globe are the social and economic condi-
tions in which people work and live, regarding chronic
pain as a global public health priority could shift the
emphasis to funding research directed at the root struc-
tural, social and cultural factors that shape pain and its
inequitable global distribution.
Summary
The high prevalence and incidence of global chronic
pain, its substantial and growing comorbidities, and its
linkage with myriad social and economic determinants
collectively provide ample justification for regarding pain
as a public health priority. Moreover, there are significant
public policy consequences for doing so. Thinking about
global chronic pain as a public health priority implies
immediately that the global focus on access to essential
medicines like opioids is insufficient as a primary policy
strategy. A public health focus requires stakeholders to
heed Rose’s insistence that ministering to the health of
populations necessitates attention to the causes of the
causes [45,46]. Chronic pain, akin to most diseases on
the planet, is strongly determined by the social and eco-
nomic conditions in which people work and live [47].
However important essential medicines are to treating
chronic pain, a public health model recommends that
significant global attention and resources be shifted to
the macrosocial determinants that most powerfully shape
the patterns of chronic pain, its comorbid diseases, and
the distribution of both. This shift in policy from the
micro-level focus on the provision of health care services
to a macro-level approach addressing the structural
determinants of health dovetails with a number of prac-
tices and reports urging the same kind of health policy
shift, including but not limited to the World Health
Organization, the Marmot Review, and the Commission
to Build a Healthier America.
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